Alaunos Therapeutics (TCRT)
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of ob...
- Open
- 1.260
- High
- 1.350
- Low
- 1.220
- Prev. Close
- 1.200
- Volume
- 672.65K
- Turnover
- 870.52K
- Avg Price
- 1.294
- Bid/Ask Ratio
- --
- Amplitude
- 10.83%
- 52wk High
- 4.590
- Volume Ratio
- 34.80
- Turnover Ratio
- 33.96%
Alaunos Therapeutics Analyst Rating
View moreForecast & Rating
Feb 15, 2024Price forecast
$205.5016209.52%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- US Stock Market Update · Sep 18 at 11:49 PM
Alaunos Therapeutics surges 14% in after-hours on $1.1M financing deal
- US Stock Market Update · Sep 18 at 09:07 PM
Alaunos Therapeutics Surges 9% After Hours on $1.1M Funding and Charter Amendment
- benzinga_article · Sep 18 at 09:06 PM
12 Health Care Stocks Moving In Friday's After-Market Session
- US Stock Market Update · Sep 18 at 07:12 PM
Alaunos Therapeutics Plunges 21% After Completing $1.12M Direct Offering
- US Stock Market Update · Sep 18 at 06:00 PM
Alaunos Therapeutics plunges 22% after $1.12 mln direct offering
- benzinga_article · Sep 18 at 05:05 PM
12 Health Care Stocks Moving In Friday's Intraday Session
